Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eric Martin

Vascular Surgery Fort Gordon, GA Doctor of Osteopathy

NPI 1871708222 CMS profile 357867

300 W Hospital Rd, Fort Gordon, GA 30905

Open in the dashboard

General payments

$64,376

101 records reported · program years 2019–2025

Research payments

$13,700

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eric Martin of Fort Gordon, GA is reported in the CMS Open Payments database as having received $64,376 across 101 general payments and $13,700 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $29,608 36
2025 Research $13,700 1
2024 General $31,864 27
2023 General $871 8
2022 General $584 6
2021 General $170 4
2020 General $95 5
2019 General $1,185 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Martin
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Eric Martin were reported at $29,608. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Eric Martin Vascular Surgery median Middle half National median
2019 $1,185 $796 $226–$2,363 $163
2020 $95 $348 $118–$1,110 $114
2021 $170 $471 $158–$1,421 $132
2022 $584 $725 $222–$2,183 $149
2023 $871 $836 $257–$2,440 $160
2024 $31,864 $909 $252–$2,619 $164
2025 $29,608 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Kerecis Limited $41,443 27 payments
  2. Organogenesis Inc. $9,234 15 payments
  3. Integra LifeSciences Corporation $9,164 7 payments
  4. W. L. Gore & Associates, Inc. $2,602 20 payments
  5. Silk Road Medical, Inc. $816 5 payments
  6. Cardiovascular Systems Inc. $369 7 payments
  7. Cook Medical LLC $157 5 payments
  8. Janssen Pharmaceuticals, Inc $112 1 payment
  9. Inari Medical, Inc. $106 1 payment
  10. Penumbra, Inc. $76 1 payment
  11. Other $298 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $34,475 6 payments
  2. Travel and Lodging $10,963 25 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,860 3 payments
  4. Food and Beverage $5,378 65 payments
  5. Consulting Fee $5,250 1 payment
  6. Honoraria $450 1 payment
Products named General payments · program years 2019–2025
  1. Kerecis Omega3 SurgiClose $21,299 8 payments
  2. Kerecis Omega3 Marigen Wound Care $21,299 8 payments
  3. Kerecis Omega3 Marigen Wound Care $21,299 8 payments
  4. Kerecis Omega3 Marigen Wound Care $21,299 8 payments
  5. Kerecis Omega3 Marigen Wound Care $21,299 8 payments
  6. Kerecis SurgiClose Wound Care $20,144 19 payments
  7. Kerecis GraftGuide $20,144 19 payments
  8. Kerecis SurgiClose Wound Care $20,144 19 payments
  9. Kerecis SurgiClose Wound Care $20,144 19 payments
  10. Kerecis SurgiClose Wound Care $20,144 19 payments
  11. Other $35,156 98 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Kerecis Limited $13,700 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

172

Median for Vascular Surgery: 122

Drug cost

$16,510

Median for Vascular Surgery: $14,135

Branded share of claims

38.4%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 11 $14,654
Atorvastatin Calcium Generic 85 $997
Clopidogrel Clopidogrel Bisulfate Brand 44 $530
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 11 $169
Rosuvastatin Calcium Generic 21 $161

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$39,361

Medicare's payments for the services billed

Medicare patients

125

Average age 73

Services billed

317

42 women, 83 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 60%
Arthritis 50%
Diabetes 49%
COPD 43%
Chronic kidney disease 42%
Heart failure 41%
Depression 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

102 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record